Scrip Asia 100 - GSK takes the flexible approach to Asian growth
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline's approach to growing its business across the Asia-Pacific region recognises the need for distinct strategies tailored to each national market. This may involve a blend of price cuts, regional co-promotion partnerships and targeted M&A deals. The company also realises that innovation can come from any source, Marc Dunoyer tells Ian Haydock in an exclusive one-on-one interview.